Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: facts?

Thanks for the recap. I was following this fairly closely right up until .25/share. Then, when the reality of the low(by some standards) award amount, became somewhat of an obstacle with PTSC maintaining the PPS level; I wanted to look back and recall exactly how the whole thing went down. The 262 million in licensing fees Lamb deems still reasonable, remains a lot of money for PTSC. I understand our hopes with getting a redo from the ITC to help increase that amount. However, I'm not quite understanding why we haven't added any licenses just based on the NDoC win.

Thanks again.

Share
New Message
Please login to post a reply